Meta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) posted a stronger-than-expected revenue in the third quarter of 2025, but a massive one-time tax charge sent earnings per share tumbling, sending shares sharply lower in after-hours trading.
GAAP EPS fell to $1.05, down 83% year-on-year and well below the $2.29 estimate, due to a $15.9 billion one-time, non-cash tax charge related to the implementation of the US Corporate Alternative Minimum Tax. Excluding this charge, EPS would have been $7.25, up 20% year-on-year.
Lululemon Athletica Inc (NASDAQ:LULU) is facing potential margin pressure as the company increases its focus on outerwear, according to analysts from Jefferies.
The analysts noted that the brand is dedicating significant in-store and online space to the category but cautioned that early signs of discounting could weigh on profitability.
Nvidia Corp (NASDAQ:NVDA, ETR:NVD) has become the first company in history to reach a market value above $5 trillion, extending its lead as the biggest beneficiary of the global artificial intelligence boom.
Shares of the chipmaker jumped as much as 3.4% at the market open, lifting its market capitalization past the $5 trillion mark for the first time. The stock was last up around 4% at nearly $209.
Fiserv (NYSE:FI) shares plunged almost 45% after the global provider of payments and financial services technology solutions reported disappointing financial results for the third quarter of 2025, with both earnings and revenue coming in below analyst expectations.
The company reported Q3 earnings per share (EPS) of $2.04, falling short of the $2.65 expected by analysts.
Etsy Inc (NASDAQ:ETSY, ETR:3E2) on Wednesday reported third quarter 2025 earnings that topped Wall Street expectations but revealed a 6.5% decrease in gross merchandise sales (GMS) and a decline in active buyers and sellers.
The online marketplace also announced that its CEO Josh Silverman will step down from his position and move to the role of executive chair at the end of the year.
Boeing Co (NYSE:BA, ETR:BCO) reported mixed financial results for the third quarter, with revenue topping expectations on higher commercial airplane deliveries.
Revenue was $23.3 billion, up 30% from the year-ago quarter, and ahead of the Wall Street consensus estimates of $22.3 billion.
Artemis Resources Ltd (ASX:ARV, AIM:ARV, OTCQB:ARTTF) shares surged 14% to 0.43p in London, after the company reported a standout intercept from first drilling at its Titan East prospect in Western Australia.
The initial reverse-circulation hole testing an interpreted shear zone returned 5m at 13.1g/t gold from 132m, including 3m at 20.9g/t from 133m, within a 20m mineralised interval.
Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) shares climbed as much as 8% in early trading after the biotech company said US regulators had cleared its experimental CAR-T therapy for leukaemia to move to a higher dose level in its ongoing Phase I trial.
The independent Data Safety Monitoring Board, which oversees the study, reviewed safety data from the first three adult patients treated with Hemogenyx’s HG-CT-1 therapy for relapsed or refractory acute myeloid leukaemia and found no dose-limiting toxicities. As a result, the trial can now advance to the next dose cohort.
80 Mile PLC (AIM:80M, OTCQB:BLLYF) shares rose almost 10% after the company saw its run of positive news continue.
The latest catalyst came in the form of an announcement from its US joint venture partners regarding an independent assessment and prospective resources report that set out the "world-class potential" of the Jameson land basin in Eastern Greenland.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) shares rose 9% to 94.47p after the mining royalty company reported record third-quarter earnings, fuelled by surging income from its copper and cobalt assets and the resumption of mining at its Kestrel coal royalty area.
Total portfolio contribution, Ecora’s measure of royalty and streaming income, more than doubled to $25 million in the three months to September, from $11.8 million in the previous quarter.
GSK PLC (LSE:GSK, NYSE:GSK) shares rose 4% to 1,707p after the pharmaceutical group raised its full-year guidance and delivered quarterly results that topped forecasts across almost every metric.
The upbeat figures, helped by a strong performance in Specialty Medicines and vaccines, also prompted positive analyst commentary, with Jefferies reaffirming its 'buy' rating and setting a price target of 2,000p.
UBS Group AG (NYSE:UBS) shares rose 3% to 31.86 CHF after reporting stronger-than-expected third-quarter results, lifted by gains in its trading and wealth management businesses and a one-off boost from releasing legal provisions.
The Swiss bank posted a net profit of $2.5 billion for the three months to September, up 74% on the same period last year and well ahead of analyst forecasts of $1.1 billion. Revenue rose 3% to $12.8 billion.